Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02553941
Title Ibrutinib and Azacitidine for Treatment of Higher Risk Myelodysplastic Syndrome
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of California, Davis
Indications

myelodysplastic syndrome

Therapies

Azacitidine + Ibrutinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.